Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke.

Majidi S, Simpkins AN, Leigh R; NIH Natural History of Stroke Investigators.

J Neuroimaging. 2018 Dec 3. doi: 10.1111/jon.12587. [Epub ahead of print]

PMID:
30508260
2.

Recurrent thrombolysis of a stuttering lacunar infarction captured on serial MRIs.

Naqvi I, Simpkins AN, Cullison K, Elliott E, Reyes D, Leigh R, Lynch JK.

eNeurologicalSci. 2018 Oct 30;13:14-17. doi: 10.1016/j.ensci.2018.10.001. eCollection 2018 Dec.

3.

Blood-ocular barrier disruption in patients with acute stroke.

Hitomi E, Simpkins AN, Luby M, Latour LL, Leigh RJ, Leigh R.

Neurology. 2018 Mar 13;90(11):e915-e923. doi: 10.1212/WNL.0000000000005123. Epub 2018 Feb 7.

PMID:
29438039
4.

White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors.

Gupta N, Simpkins AN, Hitomi E, Dias C, Leigh R; NIH Natural History of Stroke Investigators.

J Stroke Cerebrovasc Dis. 2018 Feb;27(2):466-471. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.026. Epub 2017 Oct 31.

PMID:
29100854
5.

Early Change in Stroke Size Performs Best in Predicting Response to Therapy.

Simpkins AN, Dias C, Norato G, Kim E, Leigh R; NIH Natural History of Stroke Investigators.

Cerebrovasc Dis. 2017;44(3-4):141-149. doi: 10.1159/000477945. Epub 2017 Jul 7.

6.

Stuttering lacunar infarction captured on serial MRIs.

Tahsili-Fahadan P, Simpkins AN, Leigh R, Merino JG.

Neurol Clin Pract. 2016 Oct;6(5):e37-e39. No abstract available.

7.

Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.

Simpkins AN, Dias C, Leigh R; National Institutes of Health Natural History of Stroke Investigators.

Stroke. 2016 Sep;47(9):2405-8. doi: 10.1161/STROKEAHA.116.013805. Epub 2016 Jul 26.

8.

Cytochrome P450 eicosanoids and cerebral vascular function.

Imig JD, Simpkins AN, Renic M, Harder DR.

Expert Rev Mol Med. 2011 Mar 1;13:e7. doi: 10.1017/S1462399411001773. Review.

9.

Soluble epoxide hydrolase inhibition modulates vascular remodeling.

Simpkins AN, Rudic RD, Roy S, Tsai HJ, Hammock BD, Imig JD.

Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H795-806. doi: 10.1152/ajpheart.00543.2009. Epub 2009 Dec 24.

10.

Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.

Simpkins AN, Rudic RD, Schreihofer DA, Roy S, Manhiani M, Tsai HJ, Hammock BD, Imig JD.

Am J Pathol. 2009 Jun;174(6):2086-95. doi: 10.2353/ajpath.2009.080544. Epub 2009 May 12.

11.

Single slice method for quantification of hemorrhagic transformation using direct ELISA.

Hilali HM, Simpkins AN, Hill WD, Waller JL, Knight RA, Fagan SC.

Neurol Res. 2004 Jan;26(1):93-8.

PMID:
14977065

Supplemental Content

Loading ...
Support Center